The Gamma-glutamyl Transpeptidase to Platelet Ratio (GPR) Predict Significant Liver Fibrosis and Cirrhosis in Chronic Egyptian HCV Patients

Nada, Ali(MD)1; Sabry, Aliaa (MD); Elabd (MD),  Naglaa S

Nada, Ali(MD)1; Sabry, Aliaa (MD); Elabd (MD), Naglaa S.

Afiliación

Nada, Ali(MD)1; Hepatology and Gastroenterology, National Liver Institute, Menoufia university. Menoufia. EG
Sabry, Aliaa (MD); Hepatology and Gastroenterology, National Liver Institute, Menoufia university. Menoufia. EG
Elabd (MD), Naglaa S; Department of Tropical Medicine, Faculty of Medicine, Menoufia University. Menoufia. EG

Afro-Egypt. j. infect. enem. dis ; 10(2): 226-232, 2022. tables, figures

Article en En | AIM | ID: biblio-1426647

Biblioteca responsable: CG1.1

ABSTRACT

ABSTRACT

Non- invasive parameters of liver fibrosis are being widely incorporated and adopted in clinical practice, of them, 2 ratios APRI and FIB-4 were proposed and applied. The gamma-glutamyl transferase -to platelet ratio (GPR) was developed and investigated as available test that is useful in predicting liver fibrosis stages in chronic HBV patients. We aimed to estimate the diagnostic performance of GPR compared to APRI in assessing different fibrosis stages estimated by ultrasound based Transient Elastography in chronic HCV Egyptian patients

Asunto(s)

Humanos; Plaquetas; gamma-Glutamiltransferasa; Hepacivirus; Glutamato-Cisteína Ligasa; Cirrosis Hepática

Palabras clave

Chronic HCV, Liver fibrosis, Non-invasive test

Texto completo

Añadir a Mi BVS

Imprimir

XML

Buscar en Google

Texto completo: 1 Base de datos: AIM Asunto principal: Plaquetas / Gamma-Glutamiltransferasa Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Afro-Egypt. j. infect. enem. dis Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

Buscar en Google